In addition, our center collected human bone marrow blood samples for testing and found that S100A4 protein expression was higher in patients with primary diagnosed AML than in normal donors, and S100A4 protein levels were higher in patients with relapsed AML than in patients with primary diagnosis and in normal donors (Table 1; Figures 7E,F). Here, S100A4 is linked to acute myeloid leukemia.